Attached files
| file | filename |
|---|---|
| 8-K - U.S. Stem Cell, Inc. | d27410.htm |
| EX-8.2 - U.S. Stem Cell, Inc. | d27410_ex8-2.htm |
|
|
|
|
|
Internal Revenue Service - QTDP |
|
Department of the Treasury |
|
Mail Stop 7900 Attn: ATSU 84404 |
|
|
|
973 North Rulon White Boulevard |
|
|
|
Ogden, UT 84404 |
|
Date: |
|
|
|
October 29, 2010 |
|
|
|
|
|
|
|
Contact Person: |
|
|
|
Wandalee McLaughlin |
|
|
|
|
|
|
|
Employee Identification Number: |
|
|
|
1001023100 Contact |
|
Peggy Farley |
|
Telephone Number: |
|
Bioheart, Inc. |
|
651-312-2109 (Not Toll Free) |
|
13794 N.W. 4th Street Suite 212 |
|
|
|
Sunrise, FL 33325 |
|
|
Dear Applicant:
This letter is in response to the application submitted by Bioheart, Inc., 65-0945967, on June 25, 2010, requesting certification for qualified investments in a qualifying therapeutic discovery project under section 48D of the Internal Revenue Code for:
MARVEL Trial REGEN Trial
Based on the information submitted in the application for this project, we hereby certify $ 488,958.48 of qualified investment. Accordingly, a grant in the amount of $ 244,479.24 has been approved. Please see the enclosed for additional information.
If you have any questions, please contact the person whose name and number are shown above.
|
|
|
|
|
|
|
Sincerely Yours, |
|
|
|
|
|
|
|
/s/ Glenn DeLoriea |
|
|
|
|
|
Enclosures: |
|
Glenn DeLoriea |
|
|
|
Program Manager |
CC:
Peggy A.
Farley
|
|
|
|
10100 |
Letter 4615 (6-2010) |
|
|
Catalog Number: 55193C |